Adlumin
United States
- Washington, District of Columbia
- 07/12/2021
- Series B
- $25,000,000
Adlumin Inc. is revolutionizing the way corporations secure sensitive data and intellectual property while achieving their compliance objectives. Business are routinely under attack by internal and external threats using rogue accounts, credential theft, and identity-based attacks to subvert defenses that can damage your reputation and bottom line. Organizations can't wait weeks for answers — they need immediate detection and response actions. Adlumin's cloud-native SIEM was built for financial institutions. Our platform analyzes customers' network data and turns it into response actions to protect against malicious activity. Our top priority is to help financial institutions comply, detect, prioritize, and respond, 24/7.
The Adlumin team has a passion for technology and solving the most difficult problems and gaps in cybersecurity. Our leadership team includes industry experts from the U.S. Intelligence Community and the world’s finest investigators.
To learn more, visit adlumin.com, call (571) 334-4777, or email info@adlumin.com.
- Industry Computer & Network Security
- Website https://adlumin.com/
- LinkedIn https://www.linkedin.com/company/adlumin-inc/
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)